ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Session date: 
Friday, November 1, 2019 - 8:00am to 9:00am
Location: 
Froedtert Hospital
9200 W. Wisconsin Ave
Helfaer Auditorium
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Target audience: 

Physicians
Allied Health Care Professionals

Learning objectives: 

Perform appropriate inital genetic/molecular testing in Acute Myeloid Leukemia patients

Apply appropriate frontline therapy for Acute Myeloid Leukemia (AML)

Recognize significant adverse reactions due to new AML therapies

Faculty & credentials: 

Presenter:

Sameem Abedin, MD

Assistant Professor

Division of Hematology and Oncology

All persons in control of content have NO relevant financial relationships to disclose.

 

Michael Frank, MD

Activity Director

Contact

Name: 
Kathy A. Rafel
Phone number: 
+1 (414) 955-0531